Press Releases from TMR Pharmaceutical Market Research Reports (3 total)
Active Pharmaceutical Ingredient Market is expected to reach US$219.60 bn by 202 …
The research report indicates that the opportunity in the global active pharmaceutical ingredient market was valued at US$134.70 bn in 2015. However, this opportunity will swell to US$219.60 bn by 2023, as the market surges at a CAGR of 6.3% between 2015 and 2023. The cardiovascular drugs segment held the largest share in the overall market in 2015. In the forecast period, this segment is anticipated to expand at a…
Multiple Patent Expirations are Coming Up, Bringing in Large Number of Generic i …
Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Allergan PLC, and Mylan N.V., were the leading manufacturers of inhalation and nasal spray generic drugs in 2014. They collectively accounted for 45.9% of the revenue generated in the market for that year.
An oligopolistic market awaits new entrants trying to earn revenue through the manufacture of inhalation and nasal spray generic drugs. A handful of companies account for leading sales and production figures…
Ban on API Imports from China to Boost Heparin Production in Europe, predicts TM …
The heparin market in Europe is rather consolidated, with the Sanofi, Aspen, Pfizer, and Leo Pharma accounting for over 65% of the market in 2015. In a new study, Transparency Market Research (TMR) has found that Sanofi is the clear leader in the Europe heparin market, enjoying a 47.5% share in 2015. Increased global sales of Lovenox can be attributed to the company’s success.
“A focus on the expansion of R&D…
